Holocarboxylase Synthetase Deficiency
Oncology·MeSH: Holocarboxylase Synthetase Deficiency
Prevalence
0.5 / 100K
0 drugs in development·0 companies·2 clinical trials
Frequently asked questions
How many clinical trials target Holocarboxylase Synthetase Deficiency?
There are 2 clinical trials targeting Holocarboxylase Synthetase Deficiency tracked by BioSniper.
What is the prevalence of Holocarboxylase Synthetase Deficiency?
The estimated prevalence of Holocarboxylase Synthetase Deficiency is approximately 0.5 per 100,000 population.
Deep-dive into Holocarboxylase Synthetase Deficiency
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis